CLOVER HEALTH INVESTMENTS, CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6217 USD | -0.53% |
|
-14.75% | -34.70% |
Financials (USD)
| Sales 2024 * | 1.28B | Sales 2025 * | 1.34B | Capitalization | 308M |
|---|---|---|---|---|---|
| Net income 2024 * | -115M | Net income 2025 * | -104M | EV / Sales 2024 * | 0.18 x |
| Net cash position 2024 * | 82.5M | Net cash position 2025 * | 71.7M | EV / Sales 2025 * | 0.18 x |
| P/E ratio 2024 * |
-2.82
x | P/E ratio 2025 * |
-3.13
x | Employees | 552 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clover Health Investments, Corp.
More recommendations
More press releases
More news
| 1 day | -0.53% | ||
| 1 week | -14.75% | ||
| Current month | -21.70% | ||
| 1 month | -22.04% | ||
| 3 months | -35.04% | ||
| 6 months | -37.30% | ||
| Current year | -34.70% |
1 week
0.61
0.72
1 month
0.610.91
Current year
0.611.04
1 year
0.611.63
3 years
0.6128.85
5 years
0.6128.85
10 years
0.6128.85
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew Toy
FOU | Founder | 45 | 14-07-16 |
Vivek Garipalli
FOU | Founder | 46 | 14-07-16 |
Terrence Ronan
DFI | Director of Finance/CFO | 64 | Jan. 01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lee Shapiro
BRD | Director/Board Member | 68 | 21-01-06 |
Vivek Garipalli
FOU | Founder | 46 | 14-07-16 |
Chelsea Clinton
BRD | Director/Board Member | 44 | 17-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 237 M€ | +0.01% | - | |
| 0.02% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 0.6217 | -0.53% | 6,246,196 |
| 24-04-16 | 0.625 | -1.76% | 5,393,628 |
| 24-04-15 | 0.6362 | -5.06% | 10,867,160 |
| 24-04-12 | 0.6701 | -5.88% | 11,338,292 |
| 24-04-11 | 0.712 | -2.37% | 4,712,349 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotes
Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Companyâs subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.
Sector
Managed Healthcare
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.6217
USD
Average target price
1.333
USD
Spread / Average Target
+114.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.70% | 308M | |
| -9.02% | 442B | |
| +7.93% | 118B | |
| -2.98% | 38.51B | |
| -29.35% | 38.99B | |
| -0.40% | 21.08B | |
| -11.92% | 3.15B | |
| -42.51% | 935M |
- Stock Market
- Equities
- CLOV Stock
